741 related articles for article (PubMed ID: 16638456)
1. Low-molecular-weight heparins in the treatment of cancer-associated thrombosis: a new standard of care?
Burris HA
Semin Oncol; 2006 Apr; 33(2 Suppl 4):S3-16; quiz S41-2. PubMed ID: 16638456
[TBL] [Abstract][Full Text] [Related]
2. Low-molecular-weight heparin in cancer-associated thrombosis: treatment, secondary prevention, and survival.
Nishioka J; Goodin S
J Oncol Pharm Pract; 2007 Jun; 13(2):85-97. PubMed ID: 17873108
[TBL] [Abstract][Full Text] [Related]
3. The role of low-molecular-weight heparins as supportive care therapy in cancer-associated thrombosis.
Cunningham RS
Semin Oncol; 2006 Apr; 33(2 Suppl 4):S17-25; quiz S41-2. PubMed ID: 16638457
[TBL] [Abstract][Full Text] [Related]
4. Cancer-associated venous thrombosis in the surgical setting.
Behranwala KA; Williamson RC
Ann Surg; 2009 Mar; 249(3):366-75. PubMed ID: 19247020
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of venous thrombosis in cancer patients: practical aspects].
Laza-Achille M; Desruennes E; Di Palma M
Bull Cancer; 2006 Mar; 93(3):271-81. PubMed ID: 16567314
[TBL] [Abstract][Full Text] [Related]
6. Warfarin versus low-molecular-weight heparin therapy in cancer patients.
Zacharski LR; Prandoni P; Monreal M
Oncologist; 2005 Jan; 10(1):72-9. PubMed ID: 15632254
[TBL] [Abstract][Full Text] [Related]
7. Low-molecular-weight heparin (LMWH) in the treatment of thrombosis.
Holzheimer RG
Eur J Med Res; 2004 Apr; 9(4):225-39. PubMed ID: 15210403
[TBL] [Abstract][Full Text] [Related]
8. Cancer-associated thrombosis: focus on extended therapy with dalteparin.
Bick RL
J Support Oncol; 2006 Mar; 4(3):115-20. PubMed ID: 16553136
[TBL] [Abstract][Full Text] [Related]
9. Management of thrombosis in cancer: primary prevention and secondary prophylaxis.
Lee AY
Br J Haematol; 2005 Feb; 128(3):291-302. PubMed ID: 15667530
[TBL] [Abstract][Full Text] [Related]
10. The use of long-term low-molecular weight heparin for the treatment of venous thromboembolism in palliative care patients with advanced cancer: a case series of sixty two patients.
Noble SI; Hood K; Finlay IG
Palliat Med; 2007 Sep; 21(6):473-6. PubMed ID: 17846086
[TBL] [Abstract][Full Text] [Related]
11. Thromboembolic prophylaxis in head trauma and multiple-trauma patients.
Latronico N; Berardino M
Minerva Anestesiol; 2008 Oct; 74(10):543-8. PubMed ID: 18475247
[TBL] [Abstract][Full Text] [Related]
12. Venous thromboembolism in the medically ill patient: a call to action.
Bergmann JF; Kher A
Int J Clin Pract; 2005 May; 59(5):555-61. PubMed ID: 15857352
[TBL] [Abstract][Full Text] [Related]
13. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
Huo MH; Muntz J
Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
[TBL] [Abstract][Full Text] [Related]
14. VTE prophylaxis for the medical patient: where do we stand? - a focus on cancer patients.
Cohen AT; Nandini B; Wills JO; Ota S
Thromb Res; 2010 Apr; 125 Suppl 2():S21-9. PubMed ID: 20434000
[TBL] [Abstract][Full Text] [Related]
15. Low-molecular-weight heparin in the treatment of deep venous thrombosis.
Hauer KE
West J Med; 1998 Oct; 169(4):240-4. PubMed ID: 9795594
[TBL] [Abstract][Full Text] [Related]
16. Venous thromboembolism and cancer: prevention and therapy.
Lee AY
Vnitr Lek; 2006 Mar; 52 Suppl 1():127-8, 130-1. PubMed ID: 16637461
[TBL] [Abstract][Full Text] [Related]
17. [Heparin and cancer].
Lykke J
Ugeskr Laeger; 2006 Dec; 168(50):4397-401. PubMed ID: 17217864
[TBL] [Abstract][Full Text] [Related]
18. Antithrombotic therapy with low molecular weight heparin in cancer patients.
Petralia P; Kakkar AK
Eur J Med Res; 2004 Mar; 9(3):119-24. PubMed ID: 15096321
[TBL] [Abstract][Full Text] [Related]
19. Optimal dosing of bemiparin as prophylaxis against venous thromboembolism in surgery for cancer: an audit of practice.
Balibrea JL; Altimiras J; Larruzea I; Gómez-Outes A; Martínez-González J; Rocha E;
Int J Surg; 2007 Apr; 5(2):114-9. PubMed ID: 17448976
[TBL] [Abstract][Full Text] [Related]
20. The use of low molecular weight heparins for the prevention of postoperative venous thromboembolism in general surgery. A survey of practice in the United States.
Caprini JA; Arcelus J; Sehgal LR; Cohen EB; Reyna JJ
Int Angiol; 2002 Mar; 21(1):78-85. PubMed ID: 11941278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
